PRME Earnings

Quarterly EPS
$-0.44
Q3 2024
$-0.32
Q4 2024
$-0.40
Q1 2025
$-0.41
Q2 2025
$-0.32
Q3 2025
$-0.26
Q4 2025
$-0.28
Q1 2026
$-0.24
Q2 2026
Latest Revenue1.2M
Latest Net Income-42109000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.241.2M-42109000+3.5%+41.5%
Q1 2026-$0.28856.0K-49122000-41.1%+30.0%
Q4 2025-$0.26838.0K-46079000-61.6%+18.8%
Q3 2025-$0.321.2M-50582000+486.1%+27.3%
Q2 2025-$0.411.1M-52591000+10.9%
Q1 2025-$0.401.5M-51890000+146.0%+9.1%
Q4 2024-$0.322.2M-42276000+54.9%
Q3 2024-$0.44209.0K-52518000+20.0%
Q2 2024-$0.460-55327000
Q1 2024-$0.44591.0K-45761000
Q4 2023-$0.710-65643000
Q3 2023-$0.550-50708000
Prime Medicine (PRME) — Earnings